Oak Ridge Investments »

Halozyme Therapeutics shares owned by Oak Ridge Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Oak Ridge Investments from 13F filings

Historical chart of Oak Ridge Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Oak Ridge Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Oak Ridge Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.5M 60k 57.24
2024-06-30 $3.3M 63k 52.36
2024-03-31 $2.9M 72k 40.68
2023-12-31 $2.8M 76k 36.96
2023-09-30 $3.1M 82k 38.20
2023-06-30 $3.1M 85k 36.07
2023-03-31 $3.3M 87k 38.19
2022-12-31 $5.3M 93k 56.90
2022-09-30 $3.8M 95k 39.54
2022-06-30 $4.2M 96k 43.99
2022-03-31 $4.0M 101k 39.88
2021-12-31 $6.4M 159k 40.21
2021-09-30 $6.6M 162k 40.69
2021-06-30 $7.6M 167k 45.41
2021-03-31 $60M 1.4M 41.69
2020-12-31 $7.8M 183k 42.71
2020-09-30 $5.9M 225k 26.28